UCB SA, Belgium’s biggest drugmaker by sales, plans to get 2 billion euros ($3 billion) of loans to
refinance debt used to buy Germany’s Schwarz Pharma AG.
It’s arranging a 500 million-euro 364-day term loan and 1.5 billion euros of three-year revolving credit with a one-year extension option, the Brussels-based company said in an e-mailed statement. BNP Paribas Fortis, Commerzbank AG, and Mizuho Financial Group Inc. are arranging the deal.
refinance debt used to buy Germany’s Schwarz Pharma AG.
It’s arranging a 500 million-euro 364-day term loan and 1.5 billion euros of three-year revolving credit with a one-year extension option, the Brussels-based company said in an e-mailed statement. BNP Paribas Fortis, Commerzbank AG, and Mizuho Financial Group Inc. are arranging the deal.